Guard Therapeutics modtager betinget godkendelse til fortsat notering

Bioteknologiselskabet Guard Therapeutics har modtaget betinget godkendelse fra Nasdaq Stockholm til fortsat notering af selskabets aktier på Nasdaq First North.

Guard Therapeutics, et svensk bioteknologiselskab, har modtaget betinget godkendelse fra Nasdaq Stockholm. Godkendelsen vedrører fortsat notering af selskabets aktier på Nasdaq First North.

Beslutningen blev annonceret den 16. juli 2026. Den gør det muligt for selskabet at forblive på markedspladsen under visse betingelser.

Relaterede artikler

Illustration of stock exchanges affected by postponed KNDS IPO amid defense stock volatility, with flags and concerned executives.
Billede genereret af AI

KNDS postpones IPO amid volatility in defense stocks

Rapporteret af AI Billede genereret af AI

The German-French defense company KNDS has postponed its planned stock market listing in Paris and Frankfurt. The firm wants to wait for better market conditions. The German government is sticking to its planned entry nonetheless.

Medical technology company SpectraCure in Lund is carrying out a rights issue that will add 34.2 million kronor if fully subscribed. The issue will finance clinical studies and regulatory applications. The share fell more than 20 percent on Monday.

Rapporteret af AI

Enhanced Group Inc. started trading on the NYSE in early May following its combination with Paradise Acquisition Corp. The telehealth firm focuses on peptides and performance-enhancing products.

Biotech company Carbiotix in Lund has been declared bankrupt. The firm was delisted from Spotlight Stock Market at the end of last year.

Rapporteret af AI

ARS Pharmaceuticals held its first quarter 2026 earnings conference call on May 15, highlighting early momentum in the new year. Company executives emphasized growth drivers including expanded access for its neffy product. The call featured forward-looking statements about the firm's commercial progress.

Danish drugmaker Novo Nordisk is taking a local compounding pharmacy to court in Pretoria to stop the sale of unregistered semaglutide products. The High Court application targets iDexis over patient safety concerns.

Rapporteret af AI

The Egyptian government has confirmed plans to list four Armed Forces-affiliated companies on the Egyptian Exchange during a Wednesday meeting chaired by Prime Minister Mostafa Madbouly.

 

 

 

Dette websted bruger cookies

Vi bruger cookies til analyse for at forbedre vores side. Læs vores privatlivspolitik for mere information.
Afvis